Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Author [ Title(Desc)] Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Picollo A, Liantonio A, Babini E, Camerino DConte, Pusch M.  2007.  Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.. J Membr Biol. 216(2-3):73-82.
Pusch M, Accardi A, Liantonio A, Guida P, Traverso S, Camerino DConte, Conti F.  2002.  Mechanisms of block of muscle type CLC chloride channels (Review).. Mol Membr Biol. 19(4):285-92.
Mack PFogarty.  2021.  Medication safety in nonoperating room anesthesiology.. Curr Opin Anaesthesiol. 34(4):443-448.
Naguib M, Gottumukkala V, Goldstein PA.  2007.  Melatonin and anesthesia: a clinical perspective.. J Pineal Res. 42(1):12-21.
Kurata J, Hemmings HC.  2015.  Memory and awareness in anaesthesia.. Br J Anaesth. 115 Suppl 1:i1-i3.
Artusio, Jr. JF.  1970.  A Method of Study. Clin Anesth. 1:275.
Borchers F, Spies CD, Feinkohl I, Brockhaus W-R, Kraft A, Kozma P, Fislage M, Kühn S, Ionescu C, Speidel S et al..  2021.  Methodology of measuring postoperative cognitive dysfunction: a systematic review.. Br J Anaesth. 126(6):1119-1127.
Goudsouzian NG, Liu LM, Savarese JJ.  1978.  Metocurine in infants and children: neuromuscular and clinical effects.. Anesthesiology. 49(4):266-9.
Park BJ, Heerdt PM.  2009.  Minimally invasive surgical techniques in the treatment of lung cancer.. Minerva Chir. 64(6):573-88.
Cave AL, Skubas NJ.  2012.  Mitral regurgitation in acute aortic insufficiency.. J Cardiothorac Vasc Anesth. 26(6):1153-5.
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG.  1999.  Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.. Anesthesiology. 90(2):425-31.
Picollo A, Liantonio A, Didonna MPaola, Elia L, Camerino DConte, Pusch M.  2004.  Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.. EMBO Rep. 5(6):584-9.
Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A et al..  2002.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.. Mol Pharmacol. 62(2):265-71.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.
Perry NW, McCoy JG, Cunningham WR, Falgout JC, Street WJ.  1976.  Multivariate visual evoked response correlates of intelligence.. Psychophysiology. 13(4):323-9.
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.